4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001144204-15-027693
CIK 0000810509operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:06 PM ET
Size
5.0 KB
Accession
0001144204-15-027693
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Sale
Common Stock
2015-05-01$1.33/sh−12,500$16,625→ 309,737 total
Footnotes (2)
- [F1]Sales effected pursuant to a 10b5-1 trading plan adopted by Mr. Larson on March 13, 2015
- [F2]Weighted average of sales prices ranging from $1.31 to $1.35 per share. Mr. Larson undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:06 PM ET
- Size
- 5.0 KB